StockWatch
·
Pharmaceuticals
Corporate Governance4 Nov 2026, 01:55 pm

Amanta Healthcare: Monitoring Agency Report for Q2 FY27

AI Summary

Amanta Healthcare Ltd has submitted its Monitoring Agency Report for the quarter ended September 30, 2026, as per SEBI regulations. The report, issued by CRISIL Ratings Limited, details the utilization of funds raised through the company's Initial Public Offer (IPO). The filing confirms no deviation from the IPO's stated objects. The net proceeds from the IPO were ₹10,315.19 lakhs, adjusted from the initial estimate due to higher-than-expected issue expenses. The report is also available on the company's website.

Key Highlights

  • Monitoring Agency Report submitted for Q2 FY27 (ended Sep 30, 2026).
  • CRISIL Ratings Limited issued the report on fund utilization.
  • No deviation from IPO objects reported.
  • Net proceeds of IPO were ₹10,315.19 lakhs.
  • Report available on Amanta Healthcare's website.